On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- Cylinder Health strengthens gut-brain leadership with new Head of Gut-Brain Health and Clinical Advisory Board appointment (Cylinder Health)
- The new era of physician independence (Medical Economics)
- “Don’t Take Shortcuts,” Endoscopy Researcher Advises (GI & Hepatology News)
- Olympus Unveils Corporate Strategy (Olympus)
- Unlocking value creation in healthcare: How AI can reverse private equity’s return challenges – Part 1: HealthTech and tech-enabled services (Lexology)
- 5 highest-paid gastroenterologists in New York City (Becker’s GI & Endoscopy)
- And Your 2025 Healio Disruptive Innovators Are … (Healio)
- The Hype and Limits of At-Home Gut Microbiome Tests (U.S. News)
